Bluebird Bio’s Gets Positive Results For Beta-Thalassemia Gene … – Labiotech.eu (blog)
Labiotech.eu (blog) |
Bluebird Bio's Gets Positive Results For Beta-Thalassemia Gene …
Labiotech.eu (blog) bluebird bio, a Swiss-US firm, has obtained interim data from two clinical studies showing its new gene therapy could eliminate the need for red blood cell transfusions in patients with beta-thalassemia. Gene Therapy for Thalassemia Shows Promise A Gene Therapy, Successful In Beta-Thalassemia, Might Lead To … Bluebird Bio One Step Closer to First Approved Drug |
